CLINICAL_TRIALS
trial_result
· 2021-06-11
Clinical Trial Update: Efficacy and Safety of APD334 in Patients With Pyoderma Gangrenosum [Phase 2]
Summary
Phase 2 trial of APD334 in pyoderma gangrenosum was terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Arena Pharmaceuticals | Conditions: Pyoderma Gangrenosum | Phase 2 | Status: TERMINATED | Results posted: 2021-06-11